We are live on ! Find out more

3,545 hedge funds and large institutions have $257B invested in Merck in 2024 Q1 according to their latest regulatory filings, with 260 funds opening new positions, 1,418 increasing their positions, 1,489 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 260 | Existing positions closed: 110

37% more funds holding in top 10

Funds holding in top 10: 177242 (+65)

31% more call options, than puts

Call options by funds: $2.99B | Put options by funds: $2.28B

21% more capital invested

Capital invested by funds: $212B → $257B (+$44.7B)

3% more funds holding

Funds holding: 3,4403,545 (+105)

0.18% more ownership

Funds ownership: 76.78%76.97% (+0.18%)

5% less repeat investments, than reductions

Existing positions increased: 1,418 | Existing positions reduced: 1,489

Holders
3,545
Holders Change
+105
Holders Change %
+3.05%
% of All Funds
50.94%
Holding in Top 10
242
Holding in Top 10 Change
+65
Holding in Top 10 Change %
+36.72%
% of All Funds
3.48%
New
260
Increased
1,418
Reduced
1,489
Closed
110
Calls
$2.99B
Puts
$2.28B
Net Calls
+$714M
Net Calls Change
+$541M

MRK Hedge Fund Activity: Q1 2024 in Review

3,545 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2024, worth a combined $257B — up 21% from $212B a quarter earlier.

Buyers outnumbered sellers: 260 funds opened new MRK positions and 110 closed out — a net gain of 150 holders — while 1,418 added to existing stakes and 1,489 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.16B. The largest seller was Charles Schwab, cutting an estimated $2.35B.

  • 3,545 institutional investors held Merck (MRK) as of Q1 2024, up from 3,440 in Q4 2023.
  • Funds reported $257B of Merck stock for Q1 2024, up 21% quarter-over-quarter.
  • 260 funds opened new Merck positions in Q1 2024 and 110 closed out, a net change of +150 holders.
  • The largest Merck buyer in Q1 2024 was Fidelity Investments, an estimated $1.16B added.
  • The largest Merck seller in Q1 2024 was Charles Schwab, an estimated $2.35B sold.

Based on aggregated 13F filings for Q1 2024.